![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TST |
Gene summary for TST |
![]() |
Gene information | Species | Human | Gene symbol | TST | Gene ID | 7263 |
Gene name | thiosulfate sulfurtransferase | |
Gene Alias | RDS | |
Cytomap | 22q12.3 | |
Gene Type | protein-coding | GO ID | GO:0000096 | UniProtAcc | Q16762 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7263 | TST | P52T-E | Human | Esophagus | ESCC | 1.69e-28 | 7.60e-01 | 0.1555 |
7263 | TST | P54T-E | Human | Esophagus | ESCC | 6.29e-13 | 3.28e-01 | 0.0975 |
7263 | TST | P56T-E | Human | Esophagus | ESCC | 2.87e-08 | 8.57e-01 | 0.1613 |
7263 | TST | P57T-E | Human | Esophagus | ESCC | 3.01e-23 | 4.87e-01 | 0.0926 |
7263 | TST | P61T-E | Human | Esophagus | ESCC | 1.31e-46 | 1.03e+00 | 0.099 |
7263 | TST | P62T-E | Human | Esophagus | ESCC | 1.26e-52 | 1.02e+00 | 0.1302 |
7263 | TST | P65T-E | Human | Esophagus | ESCC | 6.72e-66 | 1.34e+00 | 0.0978 |
7263 | TST | P74T-E | Human | Esophagus | ESCC | 6.54e-47 | 1.16e+00 | 0.1479 |
7263 | TST | P75T-E | Human | Esophagus | ESCC | 4.98e-55 | 1.22e+00 | 0.1125 |
7263 | TST | P76T-E | Human | Esophagus | ESCC | 2.99e-46 | 1.06e+00 | 0.1207 |
7263 | TST | P79T-E | Human | Esophagus | ESCC | 1.05e-15 | 3.29e-01 | 0.1154 |
7263 | TST | P80T-E | Human | Esophagus | ESCC | 9.23e-31 | 1.17e+00 | 0.155 |
7263 | TST | P82T-E | Human | Esophagus | ESCC | 1.09e-24 | 1.34e+00 | 0.1072 |
7263 | TST | P83T-E | Human | Esophagus | ESCC | 9.53e-42 | 1.18e+00 | 0.1738 |
7263 | TST | P84T-E | Human | Esophagus | ESCC | 6.57e-18 | 7.37e-01 | 0.0933 |
7263 | TST | P89T-E | Human | Esophagus | ESCC | 7.68e-17 | 1.03e+00 | 0.1752 |
7263 | TST | P91T-E | Human | Esophagus | ESCC | 1.10e-10 | 8.05e-01 | 0.1828 |
7263 | TST | P94T-E | Human | Esophagus | ESCC | 3.57e-19 | 2.22e+00 | 0.0879 |
7263 | TST | P104T-E | Human | Esophagus | ESCC | 4.65e-15 | 1.16e+00 | 0.0931 |
7263 | TST | P107T-E | Human | Esophagus | ESCC | 2.92e-24 | 5.17e-01 | 0.171 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006839 | Colorectum | AD | mitochondrial transport | 102/3918 | 254/18723 | 1.87e-12 | 3.08e-10 | 102 |
GO:0044270 | Colorectum | AD | cellular nitrogen compound catabolic process | 147/3918 | 451/18723 | 3.35e-09 | 2.23e-07 | 147 |
GO:1990542 | Colorectum | AD | mitochondrial transmembrane transport | 47/3918 | 102/18723 | 1.09e-08 | 6.52e-07 | 47 |
GO:0044282 | Colorectum | AD | small molecule catabolic process | 118/3918 | 376/18723 | 1.05e-06 | 3.55e-05 | 118 |
GO:0006403 | Colorectum | AD | RNA localization | 71/3918 | 201/18723 | 1.54e-06 | 4.76e-05 | 71 |
GO:0051236 | Colorectum | AD | establishment of RNA localization | 58/3918 | 166/18723 | 1.95e-05 | 4.01e-04 | 58 |
GO:0015931 | Colorectum | AD | nucleobase-containing compound transport | 73/3918 | 222/18723 | 2.02e-05 | 4.10e-04 | 73 |
GO:0050657 | Colorectum | AD | nucleic acid transport | 57/3918 | 163/18723 | 2.22e-05 | 4.39e-04 | 57 |
GO:0050658 | Colorectum | AD | RNA transport | 57/3918 | 163/18723 | 2.22e-05 | 4.39e-04 | 57 |
GO:0006790 | Colorectum | AD | sulfur compound metabolic process | 101/3918 | 339/18723 | 6.46e-05 | 1.07e-03 | 101 |
GO:0016054 | Colorectum | AD | organic acid catabolic process | 73/3918 | 240/18723 | 3.20e-04 | 3.81e-03 | 73 |
GO:0006520 | Colorectum | AD | cellular amino acid metabolic process | 81/3918 | 284/18723 | 1.37e-03 | 1.19e-02 | 81 |
GO:00068391 | Colorectum | SER | mitochondrial transport | 87/2897 | 254/18723 | 7.91e-14 | 3.03e-11 | 87 |
GO:19905421 | Colorectum | SER | mitochondrial transmembrane transport | 42/2897 | 102/18723 | 3.65e-10 | 4.77e-08 | 42 |
GO:00064031 | Colorectum | SER | RNA localization | 53/2897 | 201/18723 | 4.51e-05 | 1.13e-03 | 53 |
GO:00442821 | Colorectum | SER | small molecule catabolic process | 87/2897 | 376/18723 | 5.31e-05 | 1.27e-03 | 87 |
GO:00442701 | Colorectum | SER | cellular nitrogen compound catabolic process | 99/2897 | 451/18723 | 1.46e-04 | 2.86e-03 | 99 |
GO:00159311 | Colorectum | SER | nucleobase-containing compound transport | 54/2897 | 222/18723 | 3.65e-04 | 5.67e-03 | 54 |
GO:00512361 | Colorectum | SER | establishment of RNA localization | 42/2897 | 166/18723 | 6.70e-04 | 8.96e-03 | 42 |
GO:00506571 | Colorectum | SER | nucleic acid transport | 41/2897 | 163/18723 | 8.74e-04 | 1.06e-02 | 41 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa00920 | Colorectum | AD | Sulfur metabolism | 8/2092 | 10/8465 | 3.78e-04 | 2.82e-03 | 1.80e-03 | 8 |
hsa009201 | Colorectum | AD | Sulfur metabolism | 8/2092 | 10/8465 | 3.78e-04 | 2.82e-03 | 1.80e-03 | 8 |
hsa009202 | Colorectum | SER | Sulfur metabolism | 8/1580 | 10/8465 | 4.56e-05 | 5.22e-04 | 3.79e-04 | 8 |
hsa009203 | Colorectum | SER | Sulfur metabolism | 8/1580 | 10/8465 | 4.56e-05 | 5.22e-04 | 3.79e-04 | 8 |
hsa009204 | Colorectum | MSS | Sulfur metabolism | 6/1875 | 10/8465 | 1.07e-02 | 3.74e-02 | 2.29e-02 | 6 |
hsa009205 | Colorectum | MSS | Sulfur metabolism | 6/1875 | 10/8465 | 1.07e-02 | 3.74e-02 | 2.29e-02 | 6 |
hsa0092010 | Esophagus | ESCC | Sulfur metabolism | 9/4205 | 10/8465 | 1.01e-02 | 2.38e-02 | 1.22e-02 | 9 |
hsa0092011 | Esophagus | ESCC | Sulfur metabolism | 9/4205 | 10/8465 | 1.01e-02 | 2.38e-02 | 1.22e-02 | 9 |
hsa00270 | Liver | Cirrhotic | Cysteine and methionine metabolism | 27/2530 | 52/8465 | 6.98e-04 | 4.15e-03 | 2.56e-03 | 27 |
hsa002701 | Liver | Cirrhotic | Cysteine and methionine metabolism | 27/2530 | 52/8465 | 6.98e-04 | 4.15e-03 | 2.56e-03 | 27 |
hsa002702 | Liver | HCC | Cysteine and methionine metabolism | 35/4020 | 52/8465 | 3.03e-03 | 9.94e-03 | 5.53e-03 | 35 |
hsa002703 | Liver | HCC | Cysteine and methionine metabolism | 35/4020 | 52/8465 | 3.03e-03 | 9.94e-03 | 5.53e-03 | 35 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TST | SNV | Missense_Mutation | c.682N>A | p.Glu228Lys | p.E228K | Q16762 | protein_coding | tolerated(0.11) | benign(0.022) | TCGA-C5-A1BQ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | cisplatin | CR | |
TST | SNV | Missense_Mutation | c.178N>C | p.Asp60His | p.D60H | Q16762 | protein_coding | deleterious(0) | probably_damaging(0.986) | TCGA-C5-A1MK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | carboplatin | PD | |
TST | SNV | Missense_Mutation | novel | c.113N>T | p.Ser38Leu | p.S38L | Q16762 | protein_coding | tolerated(1) | benign(0) | TCGA-EA-A3Y4-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
TST | SNV | Missense_Mutation | rs148918180 | c.862C>T | p.Arg288Cys | p.R288C | Q16762 | protein_coding | tolerated(0.14) | benign(0.39) | TCGA-AA-A01R-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5-fluorouracil | PD |
TST | SNV | Missense_Mutation | c.506N>G | p.Leu169Arg | p.L169R | Q16762 | protein_coding | tolerated(0.49) | benign(0.02) | TCGA-NH-A5IV-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TST | SNV | Missense_Mutation | novel | c.311T>C | p.Leu104Pro | p.L104P | Q16762 | protein_coding | tolerated(0.15) | benign(0.123) | TCGA-AJ-A23O-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TST | SNV | Missense_Mutation | novel | c.467C>T | p.Thr156Ile | p.T156I | Q16762 | protein_coding | deleterious(0.02) | benign(0.025) | TCGA-AJ-A2QO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TST | SNV | Missense_Mutation | novel | c.510N>T | p.Glu170Asp | p.E170D | Q16762 | protein_coding | tolerated(0.31) | benign(0.003) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TST | SNV | Missense_Mutation | c.321N>A | p.Phe107Leu | p.F107L | Q16762 | protein_coding | tolerated(0.06) | benign(0.035) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TST | SNV | Missense_Mutation | c.708N>T | p.Lys236Asn | p.K236N | Q16762 | protein_coding | tolerated(0.11) | benign(0.054) | TCGA-D1-A16X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |